Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on June 12, 2026

Jun. 12, 2026

Freedomtech Solutions Launches Agentic AI Platform, Powering the Next Era of Autonomous Business

Indeterminate EIN Presswire

Jun. 12, 2026

CalendarPA Launches Zero Double Booking Guarantee for Scheduling Professionals

Indeterminate EIN Presswire

Jun. 12, 2026

InfraTech Capital Authorizes $550 Million Commitment to Expand Fiber Manufacturing

Indeterminate EIN Presswire

Jun. 12, 2026

ProHance Highlights the Urgent Need for Real-Time Productivity Visibility at SSOW Malaysia

Indeterminate EIN Presswire

Jun. 12, 2026

Churchill Promotions Marks Major Growth With Office Relocation and Multi-State Market Expansion

Indeterminate EIN Presswire

Jun. 12, 2026

HorseWood Claims Evaluated: The Horse Gelatin Trick for Natural Male Enhancement Support

Indeterminate GlobeNewswire

Jun. 12, 2026

SpaceX IPO Project Unlimited (Weiss Ratings' Michael Robinson Disruptors & Dominators Newsletter) Elon's Trillion Dollar Plan to Save AI

Indeterminate GlobeNewswire

Jun. 12, 2026

Optical Satellite Market Size and Share to Surpass $8.0 Billion by 2033, Growing at a CAGR of 15.1%

Indeterminate EIN Presswire

Jun. 12, 2026

Prime Drink Group Announces Private Placement and Agreed Resolution with Creditors

Indeterminate GlobeNewswire

Jun. 12, 2026

Groupe Prime Drink annonce un placement privé et un règlement convenu avec ses créanciers

Indeterminate GlobeNewswire

Jun. 12, 2026

CORRECTION -- Leverage Shares by Themes Launches 2X Long and -2X Short SpaceX ETFs with 0.75% Fee to Meet Unprecedented Retail Demand

Indeterminate GlobeNewswire

Jun. 12, 2026

Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes

Indeterminate GlobeNewswire

Jun. 12, 2026

Communiqué de presse : Le Tzield de Sanofi approuvé aux États-Unis comme première thérapie modificatrice de la maladie pour les patients récemment diagnostiqués avec un diabète de type 1 au stade 3

Indeterminate GlobeNewswire

Jun. 12, 2026

Avicanna Announces Closing of Non-Brokered Private Placement

Indeterminate GlobeNewswire

Jun. 12, 2026

Gencor Releases Second Quarter Fiscal 2026 Results

Indeterminate GlobeNewswire

Jun. 12, 2026

Heartland Express, Inc. Declares Regular Quarterly Dividend

Indeterminate GlobeNewswire

Jun. 12, 2026

Traws Pharma Provides Regulatory Update on Influenza Program

Indeterminate GlobeNewswire

Jun. 12, 2026

MCP Server Now Available in Tridens Monetization

Indeterminate EIN Presswire

Jun. 12, 2026

Rocket Doctor Grants Stock Options and RSUs

Indeterminate GlobeNewswire

Jun. 12, 2026

Brunswick Exploration Announces AGM Results

Indeterminate GlobeNewswire